The Pharmaletter
One To Watch
Clinigen Group
Clinigen Group is a UK-based specialty pharmaceutical and services company that provides clinical trial services and managed access programs, as well as marketing a portfolio of pharmaceutical products.
Clinigen consists of five businesses that provide medicines to patients with unmet need through clinical trials, licensed and unlicensed routes.
- Clinigen Clinical Trial Services offers specialist supply and management of comparator drugs and other commercial medicines for patients in clinical trials.
- Idis Managed Access manages early access to unlicensed investigational medicines on behalf of pharmaceutical and biotech companies.
- Idis Global Access enables access to post-approved medicines in regions where they are not commercially available but where there is a patient need.
- Clinigen Specialty Pharmaceuticals provides essential hospital only medicines to hospital pharmacists, doctors and patients.
- Link Healthcare provides local and regional commercial access to specialist pharmaceutical products focused in the regions of Asia, Africa and Australasia.
Latest Clinigen Group News
9 February 2022
8 December 2021
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze